---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-007129"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-09T23:56:48.986902+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma warrant holders approve amendment reducing exercise price to $0.11

## Summary
- Warrant holders approved amendment to reduce Tradeable Warrants exercise price to $0.11.
- 736,242 warrants voted in favor (76.4% of 963,693 outstanding), 62,429 against, 3,930 abstentions.
- Amendment also eliminates restriction on CEO Steve Slilaty's voting rights under Series B Preferred Stock.
- Special meeting of warrant holders held on October 12, 2023.

## SEC filing metadata
- accession: 0001683168-23-007129
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007129/0001683168-23-007129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007129/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-007129
- JSON: https://secwatch.observer/filing/0001683168-23-007129.json
- Plain text: https://secwatch.observer/filing/0001683168-23-007129.txt

## Key facts
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Amend the Warrant Agent Agreement to reduce the exercise price of Tradeable Warrants to $0.11 and eliminate the provision prohibiting the CEO from exercising voting rights under his Series B Preferred Stock at the 2023-10-12 meeting.
  - Outcome: passed
  - Meeting: 2023-10-12
  source text: Holders of 736,242 Tradeable Warrants voted in favor of the amendment (representing 76.4% of 963,693 outstanding Tradeable Warrants), votes against were 62,429, and there were 3,930 abstentions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007129/0001683168-23-007129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
